Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DNA Electronics Secures Funding from Genting Berhad

Published: Tuesday, April 29, 2014
Last Updated: Tuesday, April 29, 2014
Bookmark and Share
Further investment from Genting Berhad will fund development of point-of-care product line for time-critical medical applications.

DNA Electronics Ltd (DNAe) has announced that it had successfully secured the necessary funding for DNAe to develop the Genalysis® point-of-care genomic diagnostic product line.

The majority of the funding had been provided by its principal shareholder, Edith Grove Limited (a wholly owned subsidiary of Genting Berhad), with the company’s founders also making further investment.

DNAe will utilize the funding to transform the company from an R&D and licensing business to a full-fledged product company, offering point-of-care solutions for time-critical medical applications.

Combining the experience in next-generation sequencing gained from the company’s collaboration with Roche and its development of point-of-care genotyping solutions for personalized skincare analytics pioneer GENEU Limited, DNAe will develop a new product line of Genalysis® genomic diagnostic systems.

This further investment in DNAe forms part of a growing portfolio of cutting-edge healthcare companies funded by Genting Berhad. Tan Sri Lim Kok Thay, CEO and Chairman of Genting Berhad said: “We are excited about DNAe’s strategic growth plans and are delighted to provide our continued support to help the company achieve its clear market potential.”

Commenting on the further investment from Genting Berhad, CEO and Founder of DNAe Professor Chris Toumazou commented: “I would like to thank Genting Berhad for their continued strong support of DNAe, which reflects their confidence in our strategy and capability. Our label-free semiconductor sequencing technology is now proven across thousands of laboratories worldwide, through the company’s non-exclusive license to Ion Torrent, now part of Thermo Fisher Scientific. I am excited about embarking on this new chapter of growth and development of the company and making personalized genomic healthcare a tangible reality.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DNA Electronics and Ion Torrent Sign License Agreement
License offers Ion Torrent access to DNA Electronics’ intellectual property.
Tuesday, August 03, 2010
Scientific News
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Head Injury Patients Develop Brain Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
New Way to Identify Brain Tumor Aggressiveness
Looking at a brain tumor’s epigenetic signature may help guide therapy.
OncoCyte, The Wistar Institute Enter Global Licensing Agreement
Exclusive rights to commercialize biomarker assay follows years of positive collaboration on lung cancer diagnostic test.
Easier Diagnosis for Fungal Infection of the Lungs
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.
Antibiotic Susceptibility Testing
A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.
Mitochondrial Troublemakers Unmasked in Lupus
Drivers of autoimmune disease inflammation discovered in the traps of pathogen-capturing white blood cells.
DNA Analysis in the Fast Lane
Rice bioengineers' method should lead to better database of thermal behaviors.
‘Simple Rules’ Calculate Ovarian Cancer Risk
Scientists have formulated a system that uses ultrasound images to accurately work out the likelihood of an ovarian growth being cancerous.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!